| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic Lübeck, D-23538 Lübeck, Germany
Address all correspondence and requests for reprints to: Olaf Jöhren, Ph.D., Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany. E-mail: Joehren{at}medinf.mu-luebeck.de.
Hypothalamic prepro-orexin as well as pituitary and adrenal orexin receptors are gender-specifically expressed. To assess the regulation by gonadal steroids, we investigated the effect of 17ß-estradiol in female and of testosterone in male rats on prepro-orexin and orexin receptor mRNA expression. Rats were either sham-operated or gonadectomized and subsequently treated with placebo, 17ß-estradiol, or testosterone for 21 d. Tissue mRNA levels of prepro-orexin, orexin type-1 (OX1), and orexin type-2 (OX2) receptors were measured using quantitative real-time RT-PCR.
In female rats, pituitary OX1 receptor mRNA levels were increased 12-fold after ovariectomy compared with sham- operated rats. The increase of pituitary OX1 receptor mRNA was inhibited by treatment with 17ß-estradiol. Adrenal mRNA levels of OX2 receptors in ovariectomized rats were increased 2-fold compared with sham-operated rats and were also reduced by treatment with 17ß-estradiol. In male rats, orchidectomy increased the mRNA levels of pituitary OX1 receptors compared with sham-operated rats. In contrast, adrenal OX2 receptor mRNA was reduced after orchidectomy. Testosterone treatment reversed the effect of orchidectomy on pituitary OX1 and adrenal OX2 receptors. In the hypothalamus, no differences were found in the mRNA levels of prepro-orexin, OX1, and OX2 receptors between sham-operated, placebo-treated, and steroid-treated female or male rats.
Our results indicate that gonadal steroids differentially regulate pituitary OX1 receptors and adrenal OX2 receptors in male and female rats and may contribute to specific sex- dependent neuroendocrine and endocrine actions of orexins.
This article has been cited by other articles:
![]() |
P. Silveyra, V. Lux-Lantos, and C. Libertun Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E977 - E985. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Silveyra, P. N. Catalano, V. Lux-Lantos, and C. Libertun Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E820 - E828. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Voisin, A. E. Firar, V. Avondo, and M. Laburthe Orexin-Induced Apoptosis: The Key Role of the Seven-Transmembrane Domain Orexin Type 2 Receptor Endocrinology, October 1, 2006; 147(10): 4977 - 4984. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol. Rev., March 1, 2006; 58(1): 46 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Barreiro, R. Pineda, F. Gaytan, M. Archanco, M. A. Burrell, J. M. Castellano, H. Hakovirta, M. Nurmio, L. Pinilla, E. Aguilar, et al. Pattern of Orexin Expression and Direct Biological Actions of Orexin-A in Rat Testis Endocrinology, December 1, 2005; 146(12): 5164 - 5175. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karteris, R. J. Machado, J. Chen, S. Zervou, E. W. Hillhouse, and H. S. Randeva Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1089 - E1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karteris, J. Chen, and H. S. Randeva Expression of Human Prepro-Orexin and Signaling Characteristics of Orexin Receptors in the Male Reproductive System J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1957 - 1962. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |